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Abstract
Microbial species can act in synergy to circumvent environmental stress conditions and survive. In addition, biofilms are a 
serious public- health issue globally and constitute a clinical emergency. Infection persistence, increased morbidity and mor-
tality, and antibiotic resistance are consequences of poly- microbial synergy. Due to inherited complexity and synergy between 
numerous species, newer antimicrobial agents of increased efficacy and tolerability are needed. In this unique medical case, 
a chronic (9 year) multi- bacterial scalp infection was differentially diagnosed from other inflammatory skin disorders by pro-
longed microbiological culture. The bacterial species found seem to have caused lesions of visible biofilm not documented 
previously in the medical literature. This complicated infection was treated successfully and rapidly with the combined topical 
application of the active halogen compounds N- chlorotaurine, N- bromotaurine and bromamine T, which is in contrast to the 
previous failed systemic and topical therapeutic approaches. This study strengthens the case for the use of active halogen 
compounds against multi- bacterial infections of the skin in the future, without the occurrence of resistance.
InTROduCTIOn
Microbial species naturally evolve and optimize mechanisms 
to resist killing by harmful conditions, such as the presence 
of antibiotics. These mechanisms create ‘un s'en vient’ echoes 
of the resulting antimicrobial therapy failures that eventually 
compromise the practice of advanced medical microbiology. 
Poly- microbial synergy is clinically important [1]. The produc-
tion of biofilms due to microbial synergy elevates patient 
mortality and morbidity [2–5]. Complex sepsis infections 
with coagulase- negative staphylococci are linked to persistent 
colonization after antibiotic treatment on superficial sites, 
like umbilical catheters [2]. Increased mortality from initial 
infection is higher with biofilm- producing strains as compared 
to non- biofilm- producing strains [3]. Such infections may 
be complemented by frequent synergistic infections due to 
Candida species, leading to severe clinical complications [4]. 
Fifty thousand deaths per year in the USA alone result from 
persistent Candida species infections due to the production of 
biofilms [4]. Severe biofilm infections caused by Staphylococcus 
aureus and Enterobacteriaceae are also a significant issue [5].
Mixed aerobic and anaerobic bacteria species comprise poly- 
microbial synergistic infections and provide nutritionally 
distinct microenvironments for the survival of the different 
species during the infection [6–8]. Clinical investigations 
suggest that synergizing biofilm- producing bacterial strains 
account for a 300- fold elevated patient mortality as compared 
to strains that are do not produce a biofilm [9]. Microbial 
analysis of samples from chronic wounds also suggests that 
persistence of infection is tightly associated with synergizing 
bacteria, complicating the healing process [10–13].
The overwhelming resistance to antimicrobial agents due 
to bacterial synergy during infection, which is also seen for 
biofilm- forming bacteria, requires novel approaches to ensure 
successful treatment [14–16]. One not novel, but frequently 
underestimated, approach is to apply antiseptics instead of 
antibiotics, if topical treatment is possible. In this regard, 
novel substances with high tissue tolerability have become of 
interest, for instance active halogen compounds. Haloamines 
show increased antimicrobial activity compared to anti-
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have a negligible chance to develop resistance [17, 18]. 
N- Chlorotaurine (NCT) and N- bromotaurine (NBrT) are 
natural representatives of this type of compound. The tolera-
bility and efficacy of NCT for topical treatment of infections of 
different body sites has been demonstrated in clinical studies 
and single cases, for instance on the skin, in the eye, in the 
ear–nose–throat region and in the urinary bladder amongst 
others [17, 18]. NBrT has shown tolerability and efficacy in 
the treatment of acne [18]. Recently, NCT and NBrT have 
been also combined as an approach to potentiate their proper-
ties. This was a favourable therapeutic choice in the case of a 
herpes zoster infection refractory to common antivirals [19], 
and truly life- saving in the case of a multiresistant S. aureus 
chronic wound infection [20]. Moreover, both haloamines 
inhibit bacterial biofilm formation and inactivate biofilm as 
proved in vitro [21, 22], with NBrT showing superiority in 
this activity [21]. Due to the long- term structural instability of 
NBrT, however, more stable agents like bromamine T (BAT), 
with similar anti- inflammatory and antimicrobial activities, 
have been devised and considered for clinical anti- infective 
use [22].
In this case report, 9- year- old lesions of the scalp resem-
bling atypical pustular erosions with eschars proved to be 
an unidentified chronic infection of multiple, synergizing 
microbial species. From this infectious tissue, seven distinct 
bacterial species, namely Pseudomonas fluorescens, Staphy-
lococcus capitis, Staphylococcus lugdunensis, Staphylococcus 
epidermidis, Bacillus pumilus, Kocuria marina and Aerococcus 
viridans, were isolated. The infectious masses growing on and 
within the skin were resistant to previous topical and systemic 
administrations of multiple antibiotics, disinfectants, cyto-
static agents and cryosurgery. Possibly, this was due to biofilm 
formation. In the end, the infection was successfully treated 
and rapidly cured with the combined topical application of 
NCT, NBrT and BAT. Within 25 days, a totally healed skin 
tissue with complete disappearance of the infectious plaques 
was achieved.
METhOdS
Microbial culture, identification and resistance 
testing
Swabs and small fragments from the area of chronic infec-
tion were cultured on Columbia blood agar (Becton Dick-
inson) under aerobic and anaerobic conditions, for 48 days 
at 37 °C. Bacterial species were identified by matrix- assisted 
laser desorption/ionization- time of flight mass spectrometry 
(MALDI- TOF MS; Bruker Daltonics) using the direct smear 
method. A score above 1.7 was considered valid [23].
Resistance against antibiotics was assessed by disc- diffusion 
test on Müller–Hinton agar plates, according to European 
Committee on Antimicrobial Susceptibility Testing stand-
ards [24]. For those bacteria where no species- related zone- 
diameter breakpoints existed, the Etest method with PK- PD 
(non- species related) breakpoints was used. The following 
antibiotics were tested: penicillin (not for Pseudomonas 
spp.); ampicillin (not for Pseudomonas spp.); ampicillin + 
clavulanic acid (not for Pseudomonas spp. and Aerococcus 
spp.); piperacillin + tazobactam; first-, second-, third- and 
fourth- generation cephalosporins (not for Aerococcus spp. 
and only partially for Pseudomonas spp.); carbapenems; 
ciprofloxacin and levofloxacin; aminoglycosides (not for 
Aerococcus spp.); vancomycin (not for Pseudomonas spp.). For 
Staphylococcus spp., the following additional antibiotics were 
tested: clindamycin, erythromycin, doxycycline, fosfomycin, 
cefoxitin and linezolid.
Preparation of nCT, nBrT and BAT solutions
NCT and NBrT solutions at a concentration of 1.0 % (55 
mM NCT, 49 mM NBrT) were freshly prepared in distilled 
water as described previously in 2016 and 2019 [19, 20]. The 
solutions were put into sterile spray bottles, which released 
approximately 130 µl per single puff. BAT crystalline sodium 
salt was provided by the Institute of Hygiene and Medical 
Microbiology, Medical University of Innsbruck, Innsbruck, 
Austria. A 0.1 % (3.2 mM) BAT solution in distilled water was 
prepared in similar sterile spray bottles as for NCT and NBrT.
Quantitative in vitro killing assays
Tests were done in 0.1 M phosphate buffer at pH 7.1 and 37 °C 
in a water bath. Separate solutions of 1 % NCT (55 mM), 0.02 % 
NBrT (0.98 mM) and 0.001 % (32 µM) BAT were prepared in 
the buffer. Separate overnight cultures of the bacteria at 37 °C 
in tryptic soy broth were washed twice in saline and diluted 
to 1×108 c.f.u. ml−1 in saline . Bacterial suspensions of 40 µl 
were added to 3.96 ml of each test solution at time zero and 
incubated at 37 °C. After different incubation times (1, 5, 15, 
30 min), 100 µl aliquots were removed and mixed with 900 µl 
1 % methionine/1 % histidine in distilled water to inactivate 
the antiseptic. Aliquots (50 µl) were plated in duplicate on 
Columbia blood agar using an automatic spiral plater (model 
WASP 2; Don Whitley UK), allowing a detection limit of 
100 c.f.u. ml−1 taking into account both plates. Plates were 
grown at 37 °C for 48 h, and colonies were counted. Plates 
with no growth were incubated for a further 5 days. Controls 
in 0.1 M phosphate buffer without antiseptics were performed 
and showed no reduction in the number of c.f.u., as was also 
found for the respective inactivation controls [25].
RESulTS
Clinical case
An 85- year- old woman was examined in Nasco AD Biotech.
Lab. affiliated clinic for a set of pustular erosions with 
eschars growing on her scalp (Fig. 1a). A recent haematology 
examination had recorded that the patient suffered from mild 
eosinophilia [26] of 5 900 cells µl−1, a slightly low haematocrit 
level of 33.4 % and 11.1 g haemoglobin dl−1. From the exten-
sive medical record taken, there was no coherent diagnosis 
over the whole 9 years of her disease period. Prior to the 
formation of the lesions on her scalp, the patient had expe-
rienced an accidental fall from a window sill, which resulted 
in a severe bleeding wound on her scalp that required her 
hospitalization. The wounded area never healed completely. 
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Fig. 1. Treatment of the chronic multi- bacterial infection of the scalp over 60 days with a combination of 1 % NCT, 1 % NBrT and 0.1 % 
BAT. (a) Lesions growing on the elderly patient’s scalp resembled pustular erosions with eschars. (b) Assuming an infectious origin, 
some lesions were detached successfully (indicated by an arrow) by using a gauze soaked with a 1 % NCT solution. Tissue and swabs 
were collected and sent for microbial culture. (c) On day 3, treatment with 1 % NCT showed visible but slow regression of the lesions. 
Combination therapy with 1 % NCT and 1 % NBrT was commenced. (d) The next day (day 4), the 1 % NCT and 1 % NBrT combination 
treatment had accelerated the regression and softening of the lesions. (e) By the fifth day of treatment, lesions together with a 
subcutaneous portion of skin could be partly removed without serious bleeding. Application of 0.1 % BAT twice daily was commenced 
at home. (f) Evident accelerated tissue repair and almost total clearance of remaining lesions. (g) Wounds were epithelialized, with no 
evident recurrence of lesions. (h) Further epithelialization of the wounds from the previous lesions. (i) Remarkable epithelialization and 
tissue repair induced the decision to end the treatments at the clinic. (j) The skin was completely epithelialized and returned to normal 
pigmentation. Application of 0.1 % BAT was stopped.
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According to the patient's information, similar lesions to the 
ones presented to us began to develop after a month of topical 
therapy with wound dressings subsequent to her dismissal 
from the hospital. Initial histology from whole biopsy speci-
mens performed at that time (9 years ago) resulted in ulcera-
tion and inflammatory abscesses. Numerous multinucleated 
foreign body giant cells were described. This appears unusual 
to us, since these are known to develop from immune reac-
tions to biomaterials [27, 28].
A month later, the patient was hospitalized again and treated 
systemically with a combination of methylprednisone at 
1 mg−1 kg daily and cyclosporine at 5 mg−1 kg daily for 5 
days and topically with 2 % fusidic acid dressings, assuming 
pyoderma gangrenosum. Unfortunately, the treatment was of 
no benefit and the lesions worsened after a few days. Synopti-
cally, in the following 9 years, the patient was treated repeat-
edly with local iodine; gentamicin and dexamethasone cream, 
at 1 mg g−1 and 0.5 mg g−1, respectively; 2 % fusidic acid and 
1 % hydrocortisone; 2 % miconazole and 1 % hydrocortisone; 
and finally with continuous painful cryosurgeries without any 
therapeutic effect.
Microbiological investigation
Upon initial examination of the patient at our clinic, the 
lesions resembled infectious material. To obtain adequate 
material for microbiological examination, the lesions were 
soaked using sterile gauze embedded in 1 % NCT solution 
until they turned soft. In this way, material from deeper layers 
could be detached from the scalp avoiding pain or bleeding 
(Fig. 1b). Small samples from multiple biofilm- like infection 
areas, as well as swabs, were taken and subjected to aerobic 
and anaerobic culture on Columbia blood agar. Sequential 
and prolonged culturing proved our medical assumption 
by isolating a plethora of bacterial species. The bacterial 
species isolated and identified by MALDI- TOF MS were: the 
Gram- positive cocci S. lugdunensis, S. capitis, S. epidermidis, 
A. viridans and K. marina; the Gram- positive rod B. pumilus; 
and the Gram- negative rod P. fluorescens (Table 1).
Treatment with nCT, nBrT and BAT
The lesions on the scalp skin seemed to be due to a synergy 
of bacteria forming a unique chronic wound infection and 
possibly a biofilm not previously reported in medical science. 
Therefore, antimicrobial treatment at our hospital was consid-
ered. As the patient refused further systemic antibiotics, a 
novel topical application of the taurine derivatives NCT and 
NBrT was suggested, because of their high tolerability and 
antiseptic activity including against biofilms without the 
development of resistance [18–20]. As expected, all clinical 
isolates were rapidly inactivated in time- kill assays in vitro by 
the active chlorine and bromine compounds used (Table 2).
A regimen of one daily in- patient application of topical 
taurine derivatives was decided upon (Table 3, Fig. 1). The 
patient was handled according to the Declaration of Helsinki 
guidelines and gave written informed consent. Initially and 
for the first 3 days, the patient was treated for an hour with a 
gauze soaked in 1 % NCT. The NCT solution was put into a 
sterile spray bottle, releasing approximately 130 µl per single 
puff. The gauze was kept wet with the NCT solution by appli-
cation of 3–5 puffs every 5 min. Treatment with NCT resulted 
in slow but effective regression of the lesions (Fig. 1c). On 
the fourth day, to further increase the therapeutic efficacy 
noticed with 1 % NCT as seen in herpes zoster and in a crural 
purulent wound [20, 21], it was decided to proceed with a 
sequential combination of NCT and NBrT at a concentration 
of 1 % each. The treatment was altered in that for half an hour 
a gauze soaked with 1 % NCT solution was used, followed by 
a gauze soaked with 1 % NBrT solution for half an hour. The 
combination treatment of NCT and NBrT evidently acceler-
ated the therapeutic success as on the next day, i.e. the fifth 
day of treatment in total, the infection lesions turned soft 
and vastly regressed (Fig. 1d). At the end of the fifth day of 
treatment, the lesions were detached from the skin as they 
largely could be removed by simply rubbing the 1 % NBrT 
soaked gauze and without any severe bleeding (Fig. 1e). Since 
it would have been difficult for the patient to attend the clinic 
on a daily basis in the following period, it was decided to 
continue the topical treatment with NCT and NBrT at home 
Table 1. The bacterial species isolated from the chronic infection tissue: their pathogenicity and ability to form biofilms
Bacterial species Pathogenicity* Biofilm- forming ability†
P. fluorescens complex [31] Opportunistic pathogen Active biofilm formation on human cells
S. lugdunensis Opportunistic pathogen Active biofilm formation on medical devices [34]
A. viridans Opportunistic invasive pathogen [36] Not known to produce or be involved in biofilms
B. pumilus‡ Exceptional pathogen [37-39] Only known for aquatic environments [41]
K. marina‡ Emerging opportunistic and nosocomial pathogen [43-44] Known not to produce biofilms in humans [43]
S. epidermidis Opportunistic and nosocomial pathogen Biofilm- forming ability on inserted devices [47]
S. capitis Opportunistic and nosocomial pathogen Biofilm- forming ability on inserted devices under certain conditions [47]
*Strains are pathogenic in wounds, as well as in other systemic infections.
††Ability to form biofilm as a single species on human tissue, as well as on other environmental niches including plants.
‡Different species within the same genus, namely K. kristinae [45] or B. subtilis [41], are known as active biofilm producers in human infections.
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and to augment it with a 0.1 % BAT solution, which shows 
higher stability than the taurine derivatives [22]. BAT solution 
was also prepared aseptically in distilled water and given to 
the patient in a spray bottle for daily use. The patient was 
advised to use two to three puffs (approximately 150 ml per 
puff), twice per day straight onto the scalp lesions. Visits at 
the outpatient department were planned every fourth day. 
At the next visit, i.e. the ninth day of treatment, the lesions 
continued to regress. The remaining lesions from the fifth day 
had almost disappeared, and the patient’s skin tissue had been 
markedly repaired (Fig. 1f). Progression of epithelialization 
continued as recorded on days 13 and 17 of treatment with no 
signs of recurrence (Fig. 1g, h) . Tissue repair and epitheliali-
zation were remarkable on day 25 of the treatment (Fig. 1i). 
Due to the evidently healed tissue, treatments with 1 % NCT 
and 1 % NBrT were halted, while 0.1 % BAT application was 
continued at home to avoid any chance of lesion recurrence. 
Thereafter, the patient was checked for lesion recurrence on 
a monthly basis. On day 60, the previously infected tissue 
had also returned to a normal colour (Fig. 1j). It was decided 
that the 0.1 % BAT application should be discontinued. The 
patient remained healed from the lesions during 4 months 
of observation after the treatment with the active halogen 
compounds.
dISCuSSIOn
Medical importance of the bacteria isolated
The majority of studies investigating the clinical significance 
of bacterial synergy that may cause biofilms use data from 
experimental in vitro conditions to reflect clinical conditions 
[14, 29]. In this unique case of skin and subcutaneous infec-
tion with extended chronicity, the clinical microbiology inves-
tigation indicated a very interesting assortment of synergizing 
bacterial isolates. The scalp lesions were well presented and 
Table 2. The susceptibility of the clinical isolates to antibiotics and haloamines
Bacterium Resistant against* Time for ≥3log10 reduction of c.f.u. ml
−1 (min)†
1 % NCT (55 mM) 0.001 % BAT (32 µM)
0.02 % NBrT (1 mM)
P. fluorescens Imipenem, meropenem 15 1
S. lugdunensis None 15 1
A. viridans None >30‡ 1
B. pumilus Cefuroxime, fosfomycin, cefotaxime, cefepime 15 1
K. marina None 30 1
S. epidermidis Erythromycin 30 1
S. capitis Penicillin, ampicillin 30 1
*Determined by agar diffusion tests according to European Committee on Antimicrobial Susceptibility Testing standards [24].
†Tests were done in 0.1M phosphate buffer at pH 7.1 and 37 °C; 1×106 c.f.u. ml−1 were incubated in test solutions and quantitative cultures were 
assessed after inactivation of the antiseptics with 1 % methionine/1 % histidine.
‡2 log
10
 reduction after 30 min.
Table 3. Treatment and progress of healing
Day Treatment Effect
1 1 % NCT 1 h gauze Lesions detached
2–3 1 % NCT 1 h gauze Lesions regressed slowly, but clearly
4–25 1 % NCT 0.5 h gauze
1 % NBrT 0.5 h gauze
Lesions turned soft, regressed quickly and were further detached (day 5)
5–60 1 % NCT 0.5 h gauze, 1 % NBrT 0.5 h gauze,
plus 0.1 % BAT directly to the lesions
9 Almost complete lesion regression, marked tissue repair
13,17 Progression of epithelialization
25 NCT + NBrT stopped Tissue repair and healing complete
60 BAT stopped Normal skin colour
90,120,150,180 No treatment Healthy skin, no recurrence
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easily viewed macroscopically. However, to the best of our 
knowledge, there are no reports in the literature describing a 
multi- synergistic bacterial infection of the skin of this kind 
[11–16]. Multiple bacterial species were isolated from the 
overlaying infectious mass by swabs; therefore, they were 
presumptively associated with this skin and subcutaneous 
infection of the scalp. The isolates were mostly Gram- positive 
cocci apart from Gram negative rods of the P. fluorescens 
complex and Gram- positive rods of B. pumilus. It is known 
that in poly- microbial infections, a mixture of aerobic, anaer-
obic, Gram- positive and Gram- negative bacterial species 
synergize and confer metabolic advantages for co- existing 
growth [14]. Also, many of the species found readily produce 
biofilm (Table 1). It is true that these species may have been 
non- causative contaminants, but there is also a small but 
significant amount of evidence in the literature indicating 
their opportunistic virulence potential (Table 1). Strains of 
the P. fluorescens complex, although common inhabitants of 
soil and aquatic environments, recently have been considered 
of clinical significance due to the extent of their colonization 
in the lower gut and stomach microbiota in humans [30], and 
for being strong contributors to biofilm formation [31]. Their 
adaptation capacity to grow in diverse ecological niches, their 
alteration of virulence factor expression and, thus, their path-
ogenic behaviour due to their interaction with host elements 
explain their capability to produce a diversity of opportunistic 
infections [31]. Many strains of this complex are described 
as host invaders, especially during impairment of immune 
defence, and they are adequately described as human patho-
gens in various serious infections including wounds [31, 32]. 
S. lugdunensis, a coagulase- negative coccus, was also isolated 
from the tissue swabs. Strains of this species, although found 
regularly to be components of the normal skin flora and 
previously considered as non- pathogenic, recently have been 
implicated in a series of severe infections, particularly in soft 
tissue and skin [33]. Special adopted genetic machinery of 
this species is responsible for homophilic interaction between 
IsdC- containing molecules and neighbouring cells, contrib-
uting to the accumulation of biofilm in vivo [34]. A. viridans, 
also isolated from the tissue swabs, is a known opportunistic, 
pathogenic, Gram- positive coccus that does not produce 
catalase [35]. Importantly for our case, strains of this species 
contaminate hospital environments and room air. They 
gained clinical importance recently as proper identification 
distinguished them from other Gram- positive staphylococcal 
and streptococcal species [35]. Apart from serious systemic 
infections such as bacteraemia, endocarditis, meningitis and 
urinary tract infections, case studies of vasculitis and wound 
infections have been described [35, 36]. Until this report, to 
the best of our knowledge, no previous study indicated an 
involvement of A. viridans in biofilm- like lesions [14–16]. The 
clinically important B. pumilus strain was also isolated from 
the scalp tissue. Distinct from Bacillus anthracis, cutaneous 
infections clinically indistinguishable from anthrax but caused 
by B. pumilus have been described [37]. Cases of severe sepsis 
in infants and children who were otherwise immunocom-
petent patients suggest an occasional increased virulence of 
B. pumilus strains [38, 39]. The resistance to fosfomycin for 
our isolate had a medical impact (Table 2), because this anti-
biotic generally is a good choice since it penetrates into the 
biofilm and results in de- assembly of the biofilm structure 
[40]. Although most Bacillus species have the ability to produce 
biofilms in aquatic environments [41], only Bacillus subtilis is 
described as a sufficient biofilm former [42]. However, to our 
knowledge, none of the bacillus species has been implicated 
in biofilm- type infections so far, although their potential for 
involvement is alerted in the medical literature [8]. Kocuria 
micrococcal species inhabit the normal skin and mucous 
membranes of humans and animals. Although previously 
not considered as pathogenic, a recent rise in the incidence 
of both superficial infections and deep- seated or invasive 
infections is a warning [43]. An interesting case of bacterial 
sepsis by K. marina through skin breakdown is significant 
for the organism's capacity to contribute as a pathogenic 
microbe [44]. Although previous studies on clinical strains of 
K. marina showed a lack of ability to produce biofilms [43], 
other species such as Kocuria kristinae are active mucoid 
biofilm makers in dental implant placements [45]. Finally, 
amongst the coagulase- negative staphylococci, S. epidermidis 
and S. capitis, also isolated from our tissue swabs, are gaining 
clinical importance by causing increasing levels of bacte-
raemia and serious infections of newborns [46]. In particular, 
these two staphylococcal species have the capacity to produce 
biofilms and show resistance to antibiotics [47]. Therefore, 
they are considered as important contributors to this chronic 
scalp skin infection [47].
Multi-bacterial skin infection of the scalp
As already mentioned, multi- bacterial species inherently 
form consortia for protection against environmental stress 
conditions [48]. Likewise, in the clinical environment, 
chronic infections may consist of synergizing microbial 
species [14, 15]. The most studied microbial biofilm- type 
infection that involves direct adhesion to host tissue is 
infective endocarditis. Microbial vegetations are formed 
by accumulations of bacteria, platelets and fibrin, which 
are adherent to the damaged epithelium of cardiac valves. 
However, in vitro and in vivo models employed do not 
provide adequate experimental conditions that reflect the 
true image of disease etiopathogenesis and therapy [9, 49]. 
The skin and soft subcutaneous tissues provide an anatom-
ical region that is easier to investigate, diagnose and treat for 
biofilm infection. However, to investigate a chronic infection 
on the skin as a macroscopically easily viewed biofilm was 
not within the scope of this research study, due to the emer-
gency of the clinical case requiring a swift and effective treat-
ment. In the case described here, multiple pathogens may 
have synergized and caused a resistant chronic infection not 
previously described, which in many ways could have been a 
biofilm. Recently, the association between skin disease and 
biofilm infections has gained clinical importance as biofilms 
may be a serious cause of atopic dermatitis [50], the hidden 
cause of inflammatory ulcers usually diagnosed as pyoderma 
gangrenosum [27], and a hidden cause contributing to 
psoriasis pathogenesis [51].
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Within biofilms, one bacterial species may concentrate 
with numerous synergizing species and form thick layers 
of exogenous tissue, as seen in this case [1, 11]. Although 
investigation of the biofilm- making capacity of each isolate 
was not in the scope of this study, it can be speculated for 
future clinical case emergence that the identified P. fluores-
cens and Staphylococcus spp. strains, which readily produce 
biofilm in human tissue and the clinical environment, opti-
mized the conditions for the other non- biofilm forming 
species A. viridans, K. marina and B. pumilus to form 
this very well- organized thick infectious tissue overlaying 
the dermis (Fig. 1). This type of organized community of 
bacterial microcolonies resists radical elimination by anti-
biotic therapy [14, 16, 52]. Continuous recurrences during 
antibiotic treatment leave surgical removal as a sole thera-
peutic option, with no promise of success [52, 53]. This was 
also the sole therapeutic option remaining for the patient 
described here prior to attending our clinic. However, the 
pluralism of distinct microbial niches within poly- microbial 
infections makes the infection likely to persist, because the 
microbes can avoid killing by antibiotics [14, 15]. Usually, 
when antibiotics are used systematically, they only target a 
representative species mainly identified for a given systemic 
illness, letting other synergizing species live; thus, leading to 
the vast number of antimicrobial therapy failures [14, 16]. 
Resistance to the antimicrobial therapy used previously for 
the patient’s condition may be explained in this way, by 
the whole spectrum of antimicrobial resistance of all the 
isolates (Table 2), although no definite earlier diagnosis was 
ever made for our patient's infection.
Previously underestimated stress conditions, such as 
psychological induction and nutritional behaviour, further 
promote the formation of antibiotic- resistant biofilm- 
producing bacteria [54]. Under stress, the microbes take 
advantage of many kinds of host immune deficiencies, 
and the biofilm formed is either strengthened or acquires 
promoted virulence characteristics [54]. The higher age of 
our patient may also have been an important stress factor 
[55], allowing the infection to persist. In addition, the 
mild eosinophilia recorded may have paved the way for 
tissue invading infections, although this is controversial for 
bacteria [24].
The initial presumptive diagnosis for this patient was 
pyoderma gangrenosum, and the initial biopsy described 
multinucleated foreign body giant cells, which are known 
to develop in the course of immune reactions to foreign 
materials [27, 28]. It is likely that in the initial stages of 
the infection, pieces of the material that came into contact 
with the skin during the accident contained most of the 
bacteria that infected the patient. Primary histological 
examination may have identified the immune reaction of 
the skin, but not the contaminating microbes that formed 
this chronic biofilm- like infection. In this respect, the 
applied haloamines also may have counteracted immune 
responses that contributed to maintenance of the chronic 
infection [18, 28, 56].
Successful treatment of the scalp infection with 
active halogen compounds
The efficiency of haloamines to treat this infection supports 
their future use as potential agents against multi- bacterial 
infections of the skin. The primary choice to use NCT in this 
at first unclear medical case was due to the resemblance of 
the lesions to infectious ones and to the knowledge that this 
taurine derivative kills biofilms [21, 57, 58]. There is broader 
experience of clinical application of NCT compared to 
bromamines. The later combination with NBrT was initiated 
to obtain a higher efficiency in the complete destruction of 
this biofilm- type infection, which was suggestive from two 
previous skin tissue infections, namely a purulent crural 
ulceration and a herpes zoster infection [18, 19]. Bromamines 
exert markedly higher reactivity than NCT against microbes 
in killing assays in buffer solution [59]. However, for active 
halogen compounds like chloramines and bromamines, it is 
the organic matter, such as the protein load, that directs their 
efficacy against infections [59]. In the presence of organic 
matter, the activity of NCT is generally increased and may 
override that of bromamines [59]. However, bromamines are 
surprisingly well tolerated by human cells, at least on the skin 
[22, 59], so that high concentrations can be used [60]. Broad 
clinical application of NBrT may be limited by its relatively 
low stability, so active bromine compounds like BAT are 
of interest, because they have a higher stability but similar 
properties [22]. It is conceivable from the therapeutic result 
that all three agents applied helped in the complete and rapid 
eradication of this noxious chronic infection in an elderly 
patient. None of these halogens proved toxic for the patient. 
This is in agreement with our previous experimental evidence 
for a low toxicity of halogens against human cells [59] and a 
remarkable tolerability by human subjects [20, 21, 61]. No 
relapse of infection occurred, as the patient remained free of 
symptoms for many months post- treatment.
In conclusion, this was a unique case of a chronic synergistic 
infection that was successfully treated with the active halogen 
compounds NCT, NBrT and BAT. This case marks their 
potential for clinical use in similar cases. The multi- bacterial 
infection was composed of an assembly of partly unusual 
pathogens and not by predominantly biofilm- making viru-
lent bacteria like S. aureus and Pseudomonas aeruginosa [62]. 
However, these bacteria may have become life- threatening 
for the elderly patient if they had crossed the dermal barrier.
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